Chan, S. L., Bouattour, M., Yau, T., Cheng, A., Guo, Y., Peng, C., Kim, D. Y., Goyal, L., Jeng, L., Yu, M., Paik, S. W., Breder, V. V., Martin, R. C., Vogel, A., Kudo, M., Wu, J., Malhotra, U., Siegel, A. B., Llovet, J., Fan, J. (2026). Adjuvant pembrolizumab for participants with hepatocellular carcinoma and complete radiologic response after surgical resection or local ablation: The phase 3 keynote-937 study.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2026.44.2_suppl.477